Skip to main content
. Author manuscript; available in PMC: 2015 Apr 5.
Published in final edited form as: Cancer. 2013 May 29;119(17):3242–3250. doi: 10.1002/cncr.28175

Figure 1.

Figure 1

Tumor expression levels of excision repair cross-complementing gene-1 (ERCC1) and thymidylate synthase (TS) were evaluated using immunohistochemistry. Representative images are depicted (original magnification ×400). (a) Low ERCC1 expression was observed in 84 patients (77%), (b) high ERCC1 expression was observed 25 patients (23%), (c) low TS expression was observed in 61 patients (57%), and (d) high TS expression was observed in 48 patients (43%).